Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2007
11/06/2007US7291483 FGF-CX polynucleotide sequences and methods of producing same
11/06/2007US7291475 Blocking binding of alpha v beta 6 to a ligand (tenascin and fibronectin); controlling cell adhesion; pancreatic, colon, lung, and chorio cancer
11/06/2007US7291453 Isolating DNA or corresponding mRNA from a mutated Hepatitis B Virus and screening for mutations in the HBV DNA polymerase
11/06/2007US7291452 Erythrovirus and its applications
11/06/2007US7291343 Therapy for antibiotic resistance; immunotherapy
11/06/2007US7291339 Chimeric polypeptide comprising bifunctional activities for use in medical diagnostics and monitoring protein interaction
11/06/2007US7291336 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/06/2007US7291335 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/06/2007US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007US7291333 Blockade of protein C activation reduces microvascular surgical blood loss
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291331 Administering an amount of an antibody that specifically binds to OX40 ligand (OX4L) sufficient to reduce or inhibit a recall immune response in the pulmonary tissue, or respiratory tract of the mammalian subject.
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007US7291329 Antibodies against PRO4406
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/06/2007CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/06/2007CA2079879C Nucleotidic sequences coding for alpha chain variable regions in human lymphocite receptors and applications thereof
11/01/2007WO2007124463A1 Glp-1 compound/glucagon antibody compositions
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007124077A2 Immunoglobulin constant region domains with enhanced stability
11/01/2007WO2007123850A2 Recombinant attenuated clostridium organisms and vaccine
11/01/2007WO2007123771A2 Ige directed dna vaccination
11/01/2007WO2007123697A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
11/01/2007WO2007123507A1 Water-soluble conjugates for electrochemical detection
11/01/2007WO2007123242A1 SEPARATOR FOR IgG PURIFICATION, AND METHOD FOR PURIFICATION OF IgG MONOMER USING THE SAME
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122760A1 Detection reagent and detection method for influenza infection
11/01/2007WO2007122371A1 ANTI-FACTOR XIIa THERAPY
11/01/2007WO2007097934A3 Methods and compositions for using erythrocytes as carriers for delivery of drugs
11/01/2007WO2007087521A3 Cd86 and cd80 receptor competition assays
11/01/2007WO2007076422A3 Antibodies against interleukin-22 binding protein and its uses
11/01/2007WO2007076372A3 Treatment of neuroaids using inhibitors of glycogen synthase kinase (gsk)-3
11/01/2007WO2007067730A3 Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
11/01/2007WO2007064972A3 Monoclonal antibodies against amyloid beta protein and uses thereof
11/01/2007WO2007063415A3 Methods of producing stable b-lymphocytes
11/01/2007WO2007062037A3 Compositions and methods of producing hybrid antigen binding molecules and uses thereof
11/01/2007WO2007053661A3 Uses of anti-cd40 antibodies
11/01/2007WO2007024735A3 Method and antibodies for detecting nitrofuran
11/01/2007WO2007008712A8 Anti-alpha v beta 6 antibodies and uses thereof
11/01/2007WO2007005955A3 Anti-il-23 antibodies, compositions, methods and uses
11/01/2007WO2006097564A8 Novel soluble epcr protein of non-proteolytic origin and use thereof
11/01/2007WO2006094185A3 Quantification of proteins
11/01/2007WO2004032622A8 Production of peptides in plants as viral coat protein fusions
11/01/2007US20070256194 Isolated nucleic acids encoding resistance polypeptides and uses thereof
11/01/2007US20070256145 Mammalian transforming growth factor beta-9
11/01/2007US20070255044 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070255041 Bioengineered Vehicles for Targeted Nucleic Acid Delivery
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254323 Malachite green derivatives for immunoassay reagents to detect malachite green
11/01/2007US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254289 Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
11/01/2007US20070253967 Agent for the treatment and/or prophylaxis of microcirculatory disorders
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253965 Reagents for Diagnosis and Therapy of Latex Allergy and Method for the Preparation of the Same
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253962 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
11/01/2007US20070253961 Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis
11/01/2007US20070253959 Vascular endothelial cell growth factor antagonists
11/01/2007US20070253958 Human monoclonal antibodies to FC gamma receptor II (CD32)
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253952 Multifunctional and Multivalent Angiogenesis Inhibitors
11/01/2007US20070253951 Humanized c-Kit antibody
11/01/2007US20070253948 Anti-FC-gamma RIIB receptor antibody and uses therefor
11/01/2007US20070253947 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
11/01/2007US20070253946 Axon Regeneration Promoter
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253907 Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis Thereof
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007US20070253901 Atherosclerosis genes and related reagents and methods of use thereof
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007CA2649920A1 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
11/01/2007CA2649907A1 Antagonist anti-cd40 antibody pharmaceutical compositions
11/01/2007CA2649770A1 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
11/01/2007CA2649751A1 Glp-1 compound/glucagon antibody compositions
11/01/2007CA2649709A1 Immunoglobulin constant region domains with enhanced stability
11/01/2007CA2649295A1 Methods for high-throughput screening of cell lines
11/01/2007CA2649037A1 Anti-factor xiia therapy
11/01/2007CA2647768A1 Ige directed dna vaccination
11/01/2007CA2646671A1 Methods and compositions for localized secretion of anti-ctla-4 antibodies
10/2007
10/31/2007EP1850131A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849867A1 Preparation of antibody using mrl/lpr mouse
10/31/2007EP1849862A2 Media
10/31/2007EP1849860A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007EP1849479A1 Ameliorating agent for symptoms resulting from joint diseases
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1848831A2 Elisa assays using prion-specific peptide reagents
10/31/2007EP1848804A2 Anti-muci alpha beta antibodies
10/31/2007EP1848799A2 FORMS OF FACTOR XIIa
10/31/2007EP1848745A2 Monoclonal antibodies against cd30 lacking in fucosyl residues
10/31/2007EP1848744A2 Human anti-interferon gamma antibodies and methods of use thereof
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1494